Novo, Kariya Aim GLP-1s at Alzheimers, Parkinsons Last month, a real-world study linked Novos semaglutide with a 40% to 70% drop in the risk of Alzheimers disease in patients with type 2 diabetes, versus treatment with insulin
Bethea M, Bozadjieva-Kramer N, Sandoval DA
One potential reason why: Cinnamon contains several plant compounds that have antioxidant and anti-obesity properties, including cinnamaldehyde, polyphenols, and flavonols, according to a study
This helps to protect patients from unnecessary exposure to drugs that have not been shown to be safe and effective, and that offer fewer assurances of manufacturing quality
This body oil is specially formulated to enhance the skin's moisture barrier, leaving it soft, smooth, and radiant
None of these mechanisms interfere with GLP-1, GIP, or glucagon receptor signaling